ECG Findings for Lateral Wall STEMI
A lateral wall STEMI is diagnosed by ST-segment elevation ≥1 mm (0.1 mV) in at least 2 contiguous lateral leads: I, aVL, V5, and/or V6. Immediate management requires aspirin, dual antiplatelet therapy with a potent P2Y12 inhibitor (ticagrelor or prasugrel), and emergent reperfusion via primary PCI within 90 minutes of first medical contact, or fibrinolysis within 30 minutes if PCI cannot be achieved within 120 minutes 1, 2.
ECG Diagnostic Criteria
The lateral wall is represented by specific leads on the 12-lead ECG:
- High lateral wall: Leads I and aVL
- Low lateral wall: Leads V5 and V6
ST-segment elevation must be present in at least 2 contiguous leads to diagnose STEMI 2. The threshold is ≥1 mm (0.1 mV) of ST elevation in limb leads (I, aVL) and ≥1 mm in precordial leads (V5, V6).
Important Caveats
Lateral wall infarctions are frequently "electrocardiographically silent" on standard 12-lead ECG 3. In one scintigraphic study, 8 of 22 patients (36%) with confirmed lateral/posterolateral infarcts showed no ST elevation or Q waves—only ST depressions or T-wave inversions 3. This means:
- Look for reciprocal changes: ST depression in anterior leads (V1-V3) may indicate posterior or lateral ischemia
- Consider posterior leads: If clinical suspicion is high but lateral leads show only subtle changes, obtain posterior leads (V7-V9)
- Anterolateral extension: When the perfusion defect extends anterolaterally, ST elevation in lateral leads becomes more apparent 3
Immediate Management Algorithm
Step 1: Confirm STEMI Diagnosis (Within 10 Minutes of First Medical Contact)
- Obtain 12-lead ECG immediately 2
- Identify ST elevation ≥1 mm in ≥2 contiguous lateral leads (I, aVL, V5, V6)
- Correlate with ischemic symptoms (chest pain, dyspnea, diaphoresis)
- Do NOT wait for cardiac biomarkers to initiate reperfusion 1, 4
Step 2: Initiate Antithrombotic Therapy Immediately
Antiplatelet therapy 1:
- Aspirin: 300-350 mg chewable/soluble orally (or IV if unable to swallow) - Class I, Level B
- P2Y12 inhibitor (before or at time of PCI):
- Ticagrelor 180 mg loading dose, OR
- Prasugrel 60 mg loading dose (avoid if age >75, weight <60 kg, or prior stroke)
- Clopidogrel 300 mg (if <75 years) or 75 mg (if ≥75 years) only if ticagrelor/prasugrel unavailable or contraindicated
Anticoagulation 1:
- For primary PCI: Unfractionated heparin (weight-adjusted bolus + infusion)
- For fibrinolysis: Enoxaparin IV bolus followed by subcutaneous (preferred over UFH) - Class I, Level A
Step 3: Determine Reperfusion Strategy
Primary PCI is the preferred reperfusion method 1, 5, 2:
- If PCI-capable hospital: Direct to catheterization laboratory, bypass emergency department
- System goal: First medical contact-to-device time ≤90 minutes 5, 2
- If non-PCI-capable hospital: Immediate transfer with goal of ≤120 minutes to device 5
Fibrinolytic therapy (if primary PCI cannot be performed within 120 minutes) 1:
- Administer within 10 minutes of STEMI diagnosis, preferably pre-hospital 1
- Fibrin-specific agents (Class I, Level B):
- Tenecteplase, alteplase, or reteplase
- Contraindication checklist must be completed before administration 6
- Transfer to PCI-capable center immediately after fibrinolysis for angiography at 2-24 hours 1
Step 4: Rescue PCI Criteria (Post-Fibrinolysis)
Immediate rescue PCI indicated if 1:
- <50% ST-segment resolution at 60-90 minutes
- Hemodynamic instability
- Electrical instability (ventricular arrhythmias)
- Worsening ischemia
Step 5: Adjunctive Medical Therapy
Within first 24 hours 1:
- High-intensity statin: Atorvastatin 80 mg or rosuvastatin 40 mg (Class I, Level A)
- ACE inhibitor: For heart failure, LVEF <40%, diabetes, or anterior infarct (Class I, Level A)
- Beta-blocker: Oral (NOT IV) if no heart failure, hypotension, or AV block (Class I, Level A)
- Avoid IV beta-blockers in acute phase—associated with increased risk in COMMIT trial 7
Maintenance therapy 1:
- DAPT for 12 months: Aspirin 75-100 mg + ticagrelor or prasugrel (Class I, Level A)
- PPI: If high gastrointestinal bleeding risk (Class I, Level B)
Critical Pitfalls to Avoid
Don't miss isolated lateral STEMI: Standard ECG is insensitive to pure lateral/posterolateral infarcts 3. Consider additional leads (V7-V9) if clinical suspicion high but only subtle changes present.
Don't delay reperfusion for biomarkers: Cardiac troponins provide prognostic information but should never delay treatment 4.
Don't use IV beta-blockers acutely: Associated with harm in broad STEMI population 7. Use oral beta-blockers cautiously after stabilization.
Don't use fondaparinux for primary PCI: Contraindicated (Class III, Level B) 1.
Time is myocardium: Every 30-minute delay in reperfusion increases mortality. The 90-minute and 120-minute goals are maximum acceptable times, not targets 5, 7.